Food Protein-Induced Enterocolitis Syndrome in Children with Down Syndrome: A Pilot Case-Control Study.


Journal

Nutrients
ISSN: 2072-6643
Titre abrégé: Nutrients
Pays: Switzerland
ID NLM: 101521595

Informations de publication

Date de publication:
17 Jan 2022
Historique:
received: 21 12 2021
revised: 12 01 2022
accepted: 13 01 2022
entrez: 21 1 2022
pubmed: 22 1 2022
medline: 28 1 2022
Statut: epublish

Résumé

Food protein-induced enterocolitis syndrome (FPIES) is a non-immunoglobin E-mediated food hypersensitivity disorder. However, little is known about the clinical features of FPIES in patients with Down syndrome (DS). Medical records of children with DS diagnosed at our hospital between 2000 and 2019 were retrospectively reviewed. Among the 43 children with DS, five (11.6%) were diagnosed with FPIES; all cases were severe. In the FPIES group, the median age at onset and tolerance was 84 days and 37.5 months, respectively. Causative foods were cow's milk formula and wheat. The surgical history of colostomy was significantly higher in the FPIES group than in the non-FPIES group. A colostomy was performed in two children in the FPIES group, both of whom had the most severe symptoms of FPIES, including severe dehydration and metabolic acidosis. The surgical history of colostomy and postoperative nutrition of formula milk feeding may have led to the onset of FPIES. Therefore, an amino acid-based formula should be considered for children who undergo gastrointestinal surgeries, especially colostomy in neonates or early infants. When an acute gastrointestinal disease is suspected in children with DS, FPIES should be considered. This may prevent unnecessary tests and invasive treatments.

Identifiants

pubmed: 35057567
pii: nu14020388
doi: 10.3390/nu14020388
pmc: PMC8780037
pii:
doi:

Substances chimiques

Allergens 0
Dietary Proteins 0
Immunoglobulin E 37341-29-0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : Japan Society for the Promotion of Science
ID : JP18K07848
Organisme : Kawano Masanori Memorial Public Interest Incorporated Foundation for Promotion of Pediatrics
ID : 27-13
Organisme : Morinaga Foundation for Health & Nutrition
ID : None
Organisme : Grant-in-Aid for Translational Research of Yamaguchi University Hospital 2018
ID : None

Références

J Allergy Clin Immunol Pract. 2016 Mar-Apr;4(2):316-8
pubmed: 26563673
J Allergy Clin Immunol. 2011 Mar;127(3):647-53.e1-3
pubmed: 21377033
Pediatr Surg Int. 2018 Oct;34(10):1009-1017
pubmed: 30109413
Pediatrics. 2009 Dec;124(6):1565-71
pubmed: 19948627
J Allergy Clin Immunol Pract. 2019 Feb;7(2):670-672
pubmed: 30075344
Eur J Hum Genet. 2013 Jan;21(1):27-33
pubmed: 22713804
J Allergy Clin Immunol. 2019 Jan;143(1):430-433
pubmed: 30244024
Compr Ther. 1986 Feb;12(2):28-37
pubmed: 3956146
J Allergy Clin Immunol Pract. 2014 May-Jun;2(3):355-7.e1
pubmed: 24811033
Expert Rev Clin Immunol. 2011 May;7(3):317-27
pubmed: 21595598
J Allergy Clin Immunol Pract. 2013 Jul-Aug;1(4):317-22
pubmed: 24565536
J Allergy Clin Immunol. 2012 Nov;130(5):1199-200
pubmed: 22835404
Pediatr Allergy Immunol. 2015 Dec;26(8):821-3
pubmed: 25692929
Clin Exp Allergy. 2019 Sep;49(9):1178-1190
pubmed: 31468626
Clin Dev Immunol. 2009;2009:679381
pubmed: 20011655
J Allergy Clin Immunol. 2017 Feb;139(2):572-583
pubmed: 27545065
Nat Immunol. 2011 May;12(5):450-9
pubmed: 21460847
Pediatrics. 1979 Jan;63(1):80-7
pubmed: 155804
Pediatr Allergy Immunol. 2017 Dec;28(8):852-857
pubmed: 28881053
Ann Allergy Asthma Immunol. 2018 Dec;121(6):736-738
pubmed: 30121366
Clin Exp Immunol. 2012 Sep;169(3):238-43
pubmed: 22861363
J Allergy Clin Immunol. 2019 Oct;144(4):1128-1130
pubmed: 31288044
Am J Med Genet. 1999 Jun 4;84(4):340-5
pubmed: 10340648
Curr Opin Pharmacol. 2009 Aug;9(4):447-53
pubmed: 19481975
Front Immunol. 2013 Jun 19;4:152
pubmed: 23801990
Pediatrics. 2011 Aug;128(2):393-406
pubmed: 21788214
J Exp Med. 2004 Jun 21;199(12):1679-88
pubmed: 15197226
J Allergy Clin Immunol. 2017 Apr;139(4):1111-1126.e4
pubmed: 28167094
J Allergy Clin Immunol. 2015 May;135(5):1114-24
pubmed: 25956013
Annu Rev Immunol. 2006;24:99-146
pubmed: 16551245
Pediatr Allergy Immunol. 2014 Nov;25(7):651-6
pubmed: 25283440

Auteurs

Fumiko Okazaki (F)

Department of Pediatrics, Yamaguchi University Graduate School of Medicine, 1-1-1 Minamikogushi, Ube, Yamaguchi 755-8505, Japan.

Hiroyuki Wakiguchi (H)

Department of Pediatrics, Yamaguchi University Graduate School of Medicine, 1-1-1 Minamikogushi, Ube, Yamaguchi 755-8505, Japan.

Yuno Korenaga (Y)

Department of Pediatrics, Yamaguchi University Graduate School of Medicine, 1-1-1 Minamikogushi, Ube, Yamaguchi 755-8505, Japan.

Kazumasa Takahashi (K)

Department of Pediatrics, Yamaguchi University Graduate School of Medicine, 1-1-1 Minamikogushi, Ube, Yamaguchi 755-8505, Japan.

Hiroki Yasudo (H)

Department of Pediatrics, Yamaguchi University Graduate School of Medicine, 1-1-1 Minamikogushi, Ube, Yamaguchi 755-8505, Japan.

Ken Fukuda (K)

Department of Pediatrics, Yamaguchi University Graduate School of Medicine, 1-1-1 Minamikogushi, Ube, Yamaguchi 755-8505, Japan.

Mototsugu Shimokawa (M)

Department of Biostatistics, Yamaguchi University Graduate School of Medicine, 1-1-1 Minamikogushi, Ube, Yamaguchi 755-8505, Japan.

Shunji Hasegawa (S)

Department of Pediatrics, Yamaguchi University Graduate School of Medicine, 1-1-1 Minamikogushi, Ube, Yamaguchi 755-8505, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH